|
Volumn 3, Issue 6, 2000, Pages 529-530
|
Designer genes and anti-anxiety drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID A RECEPTOR;
7 TERT BUTYL 3 (2,5 DIFLUOROPHENYL) 6 (2 METHYL 2H 1,2,4 TRIAZOL 3 YLMETHOXY) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE;
ANXIOLYTIC AGENT;
CHLORDIAZEPOXIDE;
DIAZEPAM;
PROTEIN SUBUNIT;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANXIETY NEUROSIS;
CONTROLLED STUDY;
DISTRESS SYNDROME;
DRUG BINDING SITE;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
KNOCKOUT GENE;
LIGAND BINDING;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TRANQUILIZING ACTIVITY;
ANIMALS;
ANTI-ANXIETY AGENTS;
BEHAVIOR, ANIMAL;
BENZODIAZEPINES;
HYPNOTICS AND SEDATIVES;
LIGANDS;
MICE;
MICE, MUTANT STRAINS;
MUTAGENESIS, SITE-DIRECTED;
RECEPTORS, GABA-A;
SUBSTRATE SPECIFICITY;
|
EID: 0034032957
PISSN: 10976256
EISSN: None
Source Type: Journal
DOI: 10.1038/75692 Document Type: Short Survey |
Times cited : (13)
|
References (12)
|